Invention Grant
- Patent Title: Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors
- Patent Title (中): 环醚DGAT1抑制剂环醚DGAT1抑制剂
-
Application No.: US14396744Application Date: 2013-04-26
-
Publication No.: US09108956B2Publication Date: 2015-08-18
- Inventor: Sejal Patel , Justin Mao , Qian Liu , Tyler Harrison , Rohit Duvadie , Xin Chen , Frederic Zecri
- Applicant: Sejal Patel , Justin Mao , Qian Liu , Tyler Harrison , Rohit Duvadie , Xin Chen , Frederic Zecri
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Joshua Roth
- International Application: PCT/US2013/038350 WO 20130426
- International Announcement: WO2013/163508 WO 20131031
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D417/12
Abstract:
The invention relates to compounds of formula (I): useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.
Public/Granted literature
- US20150141474A1 CYCLIC ETHER DGAT1 INHIBITORSCYCLIC ETHER DGAT1 INHIBITORS Public/Granted day:2015-05-21
Information query
